Cancer News and Research

Latest Cancer News and Research

Initiation of two IPI-145 Phase 1 clinical trials triggers $4M milestone payment to Intellikine

Initiation of two IPI-145 Phase 1 clinical trials triggers $4M milestone payment to Intellikine

31 Oct 2011
Vegenics receives IND approval from FDA for VGX-100 Phase I study in late stage cancers

Vegenics receives IND approval from FDA for VGX-100 Phase I study in late stage cancers

31 Oct 2011
Infinity commences two IPI-145 Phase 1 clinical trials for hematologic malignancies

Infinity commences two IPI-145 Phase 1 clinical trials for hematologic malignancies

31 Oct 2011
Positive initial results from CytRx's INNO-206 Phase 1b/2 clinical trial for advanced solid tumors

Positive initial results from CytRx's INNO-206 Phase 1b/2 clinical trial for advanced solid tumors

31 Oct 2011
First Edition: October 31, 2011

First Edition: October 31, 2011

31 Oct 2011
AgonOx, MedImmune partner to advance OX40 agonist programs for cancer treatment

AgonOx, MedImmune partner to advance OX40 agonist programs for cancer treatment

31 Oct 2011
Centracare chooses Merge's iConnect for image interoperability, informatics strategy

Centracare chooses Merge's iConnect for image interoperability, informatics strategy

31 Oct 2011
YM BioSciences announces results of nimotuzumab Phase II study on DIPG

YM BioSciences announces results of nimotuzumab Phase II study on DIPG

31 Oct 2011
Gen-Probe receives FDA approval for APTIMA HPV assay

Gen-Probe receives FDA approval for APTIMA HPV assay

31 Oct 2011
New antibiotic regimes may increase infections after specific surgical procedures

New antibiotic regimes may increase infections after specific surgical procedures

31 Oct 2011
GC-C agonists have potential to delay progression of colitis into colon cancer

GC-C agonists have potential to delay progression of colitis into colon cancer

31 Oct 2011
Astex to present data on direct acting antiviral agents against HCV at 62nd AASLD meeting

Astex to present data on direct acting antiviral agents against HCV at 62nd AASLD meeting

31 Oct 2011
BerGenBio commences preclinical development of BGB324 anti-cancer drug

BerGenBio commences preclinical development of BGB324 anti-cancer drug

31 Oct 2011
Humana third quarter consolidated revenues increase 11% to $9.30 billion

Humana third quarter consolidated revenues increase 11% to $9.30 billion

31 Oct 2011
Fierce Vaccines highlights Inovio's VGX-3100 as one of 10 Promising Therapeutic Vaccines

Fierce Vaccines highlights Inovio's VGX-3100 as one of 10 Promising Therapeutic Vaccines

31 Oct 2011
Mayo Clinic, Oxford BioMedica collaborate to develop gene therapy for glaucoma

Mayo Clinic, Oxford BioMedica collaborate to develop gene therapy for glaucoma

31 Oct 2011
Asuragen introduces ARQ IS Calibrator Panels to improve BCR-ABL1 testing for CML

Asuragen introduces ARQ IS Calibrator Panels to improve BCR-ABL1 testing for CML

31 Oct 2011
Scientists identify key mechanism of tumor metastasis

Scientists identify key mechanism of tumor metastasis

31 Oct 2011
Weighing the cost and benefits of screenings and MRIs

Weighing the cost and benefits of screenings and MRIs

31 Oct 2011
Researchers shed light on inner workings of endocycle

Researchers shed light on inner workings of endocycle

31 Oct 2011

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback